Lilly is upping its bet on Alzheimer’s. The Indianapolis-based drug maker announced it has licensed experimental tracers that can hone in on and mark tau tangles that are believed to be a cause of...
FDA draft guidelines suggest route to approval for early-stage Alzheimer’s drugs
By
McKnight's Staff
Feb 11, 2013
The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer’s drugs.
Study: New test might help diagnose Alzheimer’s earlier
Jun 24, 2011
A new test that measures amyloid levels in the spinal fluid of people with mild cognitive impairment could help physicians more accurately predict who will develop Alzheimer’s, a new study finds.
Alzheimer’s and the magic pill
By
Liza Berger
Aug 07, 2008
They say there’s no such thing as a magic bullet, but could we have found it in the case of a cure for Alzheimer’s disease? Scientists in the field of aging were reportedly ecstatic last week when...